Citrus Bioflavonoids Market Report 2026

The citrus bioflavonoids market size has grown rapidly in recent years. It will grow from $1.32 billion in 2025 to $1.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to growing consumption of dietary supplements, increased awareness of antioxidant benefits, expansion of vitamin c fortification practices, availability of citrus processing byproducts, growth of preventive healthcare trends.

The citrus bioflavonoids market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to rising demand for immune health supplements, expansion of nutraceutical and functional food markets, increasing focus on natural ingredient sourcing, advancements in bioflavonoid extraction technologies, growing use of bioactives in pharmaceuticals. Major trends in the forecast period include increasing use of citrus-derived antioxidants in supplements, rising demand for plant-based nutraceutical ingredients, growing adoption of clean-label bioflavonoid products, expansion of bioflavonoid applications in functional foods, enhanced focus on high-purity extraction methods.

The increasing demand for natural and organic products is expected to drive the growth of the citrus bioflavonoids market in the coming years. Natural and organic products are produced using natural ingredients, without the inclusion of synthetic chemicals or artificial additives. The rising demand for these products is driven by growing health awareness, environmental concerns, and a strong preference for chemical-free alternatives. Citrus bioflavonoids are gaining considerable popularity within the natural and organic products market as consumers increasingly look for plant-based ingredients that promote overall health and wellness in a sustainable and chemical-free manner. For example, according to the Organic Trade Association, a US-based organization that supports the organic trade, U.S. organic sales reached $71.6 billion in 2024, reflecting a 5.2% increase from the previous year and double the growth rate of the overall food market. Therefore, the growing demand for natural and organic products is driving the expansion of the citrus bioflavonoids market.

Leading companies in the citrus bioflavonoids market are focused on creating innovative products that utilize Eriomin lemon fruit extract to assist with blood sugar regulation, improve metabolic health, and provide antioxidant benefits, addressing the rising consumer demand for natural, functional ingredients in health products and supplements. Eriomin is a standardized, high-potency lemon bioflavonoid blend that supports health by enhancing antioxidant activity and improving the body’s insulin response. For example, in September 2024, Lemme, a U.S.-based dietary supplement manufacturer, introduced Lemme GLP-1 Daily, a new weight management supplement featuring three main ingredients, Eriomin lemon fruit extract, Supresa saffron extract, and Morosil red orange fruit extract. This product is positioned as a natural alternative to prescription GLP-1 medications such as Ozempic, aiming to stimulate the body’s natural GLP-1 production, curb appetite, and promote healthy weight loss. It is being studied for its anti-inflammatory and antioxidant properties, which may support metabolic health and appetite regulation.

In November 2024, Miura Partners S.G.E.I.C. S.A., a Spain-based private equity firm focused on investing in sustainable natural-ingredient and specialty-chemicals companies, acquired HealthTech BioActives (HTBA) for an undisclosed amount. Through this acquisition, Miura Partners seeks to accelerate HTBA’s international growth and scale its natural-ingredient production capabilities, strengthening its ability to serve pharmaceutical, nutraceutical, food, beverage, and animal-nutrition markets worldwide. HealthTech BioActives (HTBA) is a Spain-based manufacturer specializing in citrus flavonoids and active forms of vitamin B12, along with related natural ingredients, used across health, nutrition, food and beverage, and animal-nutrition applications.

Major companies operating in the citrus bioflavonoids market are Döhler Group, Kemin Industries Inc., Herbalife Nutrition Ltd., Natural Factors USA, Green Sky Biological, Life Extension Foundation Inc., Nans Products, Country Life LLC, NutraBlend Foods LLC, Cayman Chemical, Selleck Chemicals LLC, Solgar Inc., Aloha Medicinals Inc., Bordas S.A.S, Botanic Healthcare, BOC Sciences, Freeda Vitamins Inc., Sundown Naturals, NutraScience Labs, Paradise Herbs Inc.

North America was the largest region in the citrus bioflavonoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the citrus bioflavonoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the citrus bioflavonoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The citrus bioflavonoids market consists of sales of functional foods, herbal extracts, and fortified beverages. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.